Introduction
============

Chylothorax is a condition of chyle leakage from lymphatic vessels into the pleural cavity. Post-intrathoracic surgery is the main cause of chylothorax in children with one study reporting an incidence of 0.89%.^([@B1]--[@B3])^ The same study suggested that most cases of post-operative chylothorax can be cured by a medium-chain triglyceride (MCT)-rich diet.^([@B3])^

The essential fatty acids, linoleic acid and α-linolenic acid, are long-chain polyunsaturated fatty acids that cannot be synthesized by humans because of the absence of the Δ^12^ and Δ^15^ enzymes (counting from the carboxyl terminal) necessary to insert a double bond at the ω-6 and ω-3 positions of a fatty acid carbon chain. The essential fatty acids must therefore be supplied in the diet.^([@B4])^ Most dietary triglycerides (TGs) and fat-soluble vitamins are incorporated into the chylomicrons for absorption into the lymphatic system. Intestinal absorption of fat-soluble vitamins is reduced by too little dietary fat or a lack of bile salts. Fatty acids with chain lengths of less than 12 carbon atoms are also absorbed passively across the intestinal brush-border membrane and transported through the portal vein,^([@B5])^ whereas fatty acids with chain lengths of more than 12 carbon atoms and cholesterol have a rate-limiting step when passing across the unstirred water layer of enterocytes and transported through the lymphatic vessels.^([@B6])^ Therefore MCT oil containing fatty acids with chain lengths of 8--10 carbon atoms esterified to glycerol, substituted for long-chain triglyceride (LCT) oil, is therapeutically used for primary effective treatment of post-operative chylothorax or chylopericardium.^([@B3])^

In post-operative chylothorax patients, there is concern that an MCT-rich diet will result in clinical and biochemical deficiencies in fat-soluble vitamins and fatty acids. The effects of an MCT-rich diet used for management of post-operative chylothorax on fat-soluble vitamins status and fatty acids status are not known. The aims of this study were to compare levels of fat-soluble vitamins and fatty acids in pediatric patients with post-operative chylothorax before and after treatment with an MCT-rich diet.

Materials and Methods
=====================

The study was approved by the Siriraj Institutional Review Board. The parents of all subjects gave their informed consent for their children to be included in the study.

Study design
------------

The study was a before-after study design with the same subjects.

Study subjects
--------------

In a previous study,^([@B3])^ the authors reported the incidence of post-operative chylothorax was 0.89%. The minimum required sample size for this study, calculated from the pilot study with a mean difference of linoleic acid 6.84% and a standard deviation of the difference 6.77%, α-error 5%, and β-error 20%, was determined to be eight subjects, who were then recruited from November 2008 until September 2013.

The study included children who developed chylothorax or chylopericardium after undergoing a cardiothoracic operation, for which nutritional treatment with an MCT-rich diet was prescribed. Inclusion criteria were (i) appropriate-to-age preoperative dietary intake, and (ii) postoperative fluid accumulation in either the pleural cavity or pericardial cavity proven to be chylous fluid, defined as milky sterile fluid, TG concentration \>110 mg/dl and higher than serum TG concentration, and lymphocytic predominance.^([@B7])^ Exclusion criteria were the administration of intravenous lipid emulsion and/or vitamin supplementation either prior to the diagnosis or during their treatment for chylothorax. Eleven subjects met the initial enrolment criteria of postoperative chylothorax, and nine subjects were recruited to the study.

Study procedure
---------------

Blood samples were drawn from the subjects twice, the first prior to initiation of the MCT-rich diet and the second after the chylous leakage was clinically determined to be cured and the MCT-rich diet discontinued. The MCT-rich diet was composed of non-fat milk, semisolid, or solid foods supplemented with MCT oil depending on the age of the child.

Blood sampling and analysis
---------------------------

All blood samples were analyzed for (i) fat-soluble vitamins, which were vitamin A (retinol), 25-hydroxy vitamin D (25-OHD), vitamin E (α-tocopherol), partial thromboplastin time (PTT), and prothrombin time (PT), (ii) TG and cholesterol, and (iii) plasma phospholipids and erythrocyte membrane phospholipids fatty acids.

The blood samples were placed in an EDTA-containing tube and centrifuged to collect the plasma and red blood cells, which were then stored at --20°C until analysis. All procedures for analyzing vitamins A and E were performed under light protection. Concentrations of retinol and α-tocopherol were measured by using high performance liquid chromatography as previously described.^([@B8],[@B9])^ A plasma retinol concentration of \<20 mcg/dl and a ratio of α-tocopherol to total lipids (α-TE/total lipids) of \<0.8 mg/g were considered to indicate deficiency. Analysis of 25-OHD was performed using an electrochemiluminescence immunoassay (Roche Diagnostics, IN). A serum 25-OHD concentration of \<20 ng/dl was considered to indicate deficiency.^([@B10],[@B11])^ Partial thromboplastin and prothrombin times were determined using the Dade Actin FS Activated PTT reagent and Thromborel S reagent, respectively (Siemens Healthcare Diagnostic Inc., Newark, DE). Cut-off values were derived from age-dependent references.^([@B12])^ Plasma concentrations of TG and cholesterol were measured using an enzymatic colorimetric method (Roche Diagnostics, Indianapolis, IN).

The analysis of fatty acids was performed using a gas-liquid chromatography method as described elsewhere.^([@B13],[@B14])^ The kind and amount of individual fatty acids in the plasma phospholipids and erythrocyte membrane phospholipids were calculated and the results were expressed as percentages of total fatty acids with chain lengths of 10 and 24 (C10--C24) in each sample.

Paired blood samples were analyzed for vitamin status in all nine subjects, but measured for fatty acids in only seven subjects due to incomplete blood tests.

Statistical analysis
--------------------

Statistical analysis was performed with SPSS for Windows version 15.0. Data concerning fat-soluble vitamins (retinol, 25-OHD, tocopherol, PTT, and PT) were categorized into deficient/normal groups or abnormally prolonged/normal groups according to the cut-off values, and compared by the McNemar test. Normally distributed raw data, such as retinol, 25-OHD, tocopherol levels, PTT, PT, and fatty acid levels, before and after treatment with the MCT diet, were shown as mean values and standard deviations, and then compared by paired *t* test. A *p* value less than 0.05 was deemed to be statistically significant.

Results
=======

In total, seven male and two female patients were recruited with a mean age of 4 years (SD 4.92 years, min--max 1 month--15 years). All subjects presented with post-operative chylothorax (6: right side, 2: left side, and 1: bilateral) in the absence of chylopericardium (Table [1](#T1){ref-type="table"}). Chylothorax was completely cured in all subjects and no chylous leakage reappeared in any patients after reintroduction of the normal diet.

At baseline, most of the subjects were below average in three growth parameters, %weight-for-age (7 out of 9), %length-for-age or %height-for-age (7 out of 9), and %weight-for-length or %weight-for-height (4 out of 9) (Table [1](#T1){ref-type="table"}). Initial baseline biochemical indexes found vitamin A deficiency in 3 of 9, vitamin D deficiency in 4 of 9, and vitamin K deficiency without clinical bleeding in 6 of 8 patients by minimally prolonged PT with an average difference ± SD from upper normal limit of 2.37 ± 1.52 s, but normal PTT. None had vitamin E deficiency. Warfarin, a vitamin K-antagonist, was prescribed to subject 8 before initiation of the MCT diet to treat a clot in the Glen shunt connecting the superior vena cava and the right pulmonary artery, and therefore, his blood was not analyzed for PTT and PT. Malnutrition, defined by all three growth parameters of the patients in this study, was not significantly associated with deficiencies in fat-soluble vitamins.

After treatment with the MCT diet, retinol and 25-OHD concentrations, the ratios of α-TE:total lipids, PTTs, and PTs were not statistically significantly different from the baseline data according to the cut-off values (Table [2](#T2){ref-type="table"}). Meanwhile, the mean retinol concentration increased from 33.73 to 45.07 mg/dl (*p*\<0.05) and the mean ratio of α-TE:total lipids was decreased significantly compared to the baseline data (3.78 vs 2.36 mg/g, *p*\<0.05), even though they were still within the normal ranges.

Regarding plasma and erythrocyte membrane lipids, only linoleic acid decreased significantly after treatment with the MCT diet compared to the baseline concentrations (25.25 ± 8.06% vs 14.25 ± 2.88%; *p*\<0.05, and 11.19 ± 2.15% vs 6.89 ± 2.45%; *p*\<0.05, respectively, *n* = 7), whereas the before-after concentrations of α-linolenic acid, oleic acid, arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid were not statistically different (Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}).

Discussion
==========

This study found that the mean ratio of α-tocopherol to total lipids and the values of linoleic acid in both plasma and erythrocyte membrane lipids decreased significantly after a 28-day MCT-rich diet treatment for post-operative chylothorax compared to initial values.

The rationale of managing post-operative chylothorax is to restrict the intake of long-chain fatty acids (LCFAs) from the diet in order to decrease lymphatic flow through leakage points because LCFAs are transported via chylomicrons along the lymphatic vessels. To maintain the energy density of this special diet, medium-chain fatty acids in the MCT oil are substituted for the LCFAs. An MCT-rich diet consists of non-fat milk, semisolid, or solid foods supplemented with MCT oil, depending on the patient's age and requirements.

The initial mean retinol concentration of all subjects was normal and it was increased after treatment with the MCT-rich diet, which may be explained by adequate retinol hepatic storage.

Vitamin D deficiency found prior to beginning an MCT-rich diet may reflect a low dietary intake and/or insufficient sunlight exposure from limitation of outdoor exercise due to exhaustion from cardiac disease. Inadequate sunlight exposure is a risk factor for vitamin D deficiency.^([@B15])^ No significant change in vitamin D concentration after a 28-day dietary restriction, in spite of the low natural-light UVB exposure during hospital admission and no environmental change while living at a patient's home, would seem to indicate that there was no effect of a 28-day MCT-rich diet on vitamin D status.

Although the average vitamin E status, represented as the α-tocopherol:total lipids ratio, was reduced significantly, such data did not reach the deficient cut-off value, which likely indicated that the subjects had sufficient storage prior to their surgery.

Vitamin K deficiency, which manifests as clinically significant bleeding, is shown by prolonged PT and PTT. Such values must be interpreted on the basis of the subject's age reference. The present study found that two-thirds of the subjects had minimally prolonged PT in the absence of prolonged PTT at baseline. This can be explained by (i) vitamin K is an essential factor for hepatic gamma-glutamyl carboxylase that adds a carboxyl group to glutamic acid residues on factors II, VII, IX and X. Prothrombin time is used to measure factors I, II, V, VII, and X of the extrinsic pathway of coagulation; and/or (ii) factor VII has the shortest half-life of the coagulation factors. In early vitamin K deficiency, PPT may be normal or mildly prolonged. In our study, no significant changes in the vitamin K status of our subjects after their MCT-rich diet may reflect adequate vitamin K storage prior to the 28-day diet or production by intestinal bacteria.

Linoleic acid values, but not α-linolenic acid, in both plasma and erythrocyte membrane decreased significantly after LCT-restriction for 28 days. Linoleic acid and α-linolenic acid are essential fatty acids for humans, which are required from dietary supplementation. Long-chain polyunsaturated fatty acids (PUFAs) are indispensable for the growing tissues in children especially the brain and retina, and for synthesizing eicosanoids. The dietary essential fatty acids status is reflected in the pattern of PUFAs in plasma and erythrocyte membranes.^([@B16])^ The fatty acid composition of erythrocyte membrane lipids better reflects tissue deposition than plasma lipids because of the long half-life of erythrocytes.^([@B17])^ The daily requirement of dietary α-linolenic acid is much less than that of linoleic acid.^([@B18])^ This, therefore, resulted in a non-significant reduction in plasma and erythrocyte membrane α-linolenic acid values.

The implications of the present study are as follows: (i) nutritional support through an MCT-rich diet for about 28 days is an effective treatment for post-operative chylothorax, although it may involve statistically significant decreases in linoleic acid and vitamin E. Such reductions are transient and asymptomatic; (ii) an intravenous lipid emulsion with fat-soluble vitamins may be additionally administered to prevent essential fatty acid deficiency, but a risk of catheter-related infection has to be considered; and (iii) nutritional support and sunlight exposure for children with congenital heart disease before surgery must be provided and encouraged to prevent protein-energy malnutrition and nutrient deficiencies.

In conclusion, administration of a 28-day, MCT-rich diet for treatment of post-operative chylothorax causes reduction in vitamin E concentrations, but not to a dangerous level. Linoleic acid values also decrease, but again without any significant symptoms.
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###### 

Characteristics of nine subjects with chylothorax treated with an MCT-rich diet

  Subject No.   Sex   Age           BW (kg)   Lt or Ht (cm)   %WA      %LA or %HA   %WL or %WH   Presence of chylothorax and/or chylopericardium   Duration of MCT-rich diet (days)   Result
  ------------- ----- ------------- --------- --------------- -------- ------------ ------------ ------------------------------------------------- ---------------------------------- --------
  1             F     15 years      27        138             58.7     88.46        88.52        R chylothorax                                     27                                 Cured
  2             M     11.5 months   6.5       64              69.89    85.33        95.59        R chylothorax                                     28                                 Cured
  3             M     1 month       2.7       46              65.85    84.4         100          R chylothorax                                     29                                 Cured
  4             M     5.8 years     25.1      122             128.72   107.96       111.56       L chylothorax                                     31                                 Cured
  5             M     8 months      5.1       65              62.2     92.86        72.86        L chylothorax                                     28                                 Cured
  6             M     12 months     7         70              74.47    92.72        85.37        R chylothorax                                     28                                 Cured
  7             F     8.2 years     25.1      115             109.13   92.37        128.72       B chylothorax                                     28                                 Cured
  8             M     21.6 months   6.98      74              59.15    87.57        76.7         R chylothorax                                     29                                 Cured
  9             M     2.7 years     12        89              85.71    95.7         93.02        R chylothorax                                     27                                 Cured

MCT; medium-chain triglyceride, BW; body weight, Lt; length, Ht; height, %LA; %length-for-age, %HA; %height-for-age, %WL; %weight-for-length, %WH; %weight-for-height, F; female, M; male, R; right, L; left, B; bilateral.

###### 

Biochemical index of fat-soluble vitamins before and after treatment of chylothorax with an MCT-rich diet

  Subject No.   Retinol^‡^ (mcg/dl)   25-OHD^‡^ (ng/ml)   α-TE^‡^ (µg/dl)   α-TE/total lipids^‡^ (mg/g)   PTT^‡^            PT^‡^                                                                                      
  ------------- --------------------- ------------------- ----------------- ----------------------------- ----------------- ----------------- ------------- ------------- -------------- -------------- -------------- --------------
  1             15.87                 11.19               6.69              16.45                         1366.29           684.75            NA            4.28          24.70          20.40          14.10          14.60
  2             29.99                 33.88               25.35             34.47                         1188.68           611.84            4.40          2.44          22.70          24.70          11.60          11.70
  3             25.97                 38.21               24.04             8.17                          1091.10           422.27            5.01          2.02          26.60          31.30          13.50          13.70
  4             46.36                 43.84               22.70             23.20                         629.08            616.30            2.35          3.16          27.30          28.00          14.50          14.30
  5             45.70                 66.20               26.20             23.20                         1036.17           423.08            4.26          2.03          25.10          25.90          10.90          11.70
  6             15.39                 47.80               7.29              10.40                         1458.38           770.42            3.75          1.75          25.60          39.00          16.20          22.10
  7             37.61                 69.58               11.90             4.64                          494.67            619.13            2.65          2.63          24.20          24.20          14.20          13.90
  8             68.46                 65.95               29.18             26.21                         767.38            418.00            3.97          2.53          NA             NA             NA             NA
  9             18.23                 28.97               9.94              14.02                         845.73            590.23            3.90          2.35          23.60          26.90          13.20          13.10
                                                                                                                                                                                                                       
  Mean ± SD     33.73 ± 17.65         45.07 ± 19.59       18.14 ± 9.01      17.86 ± 9.64                  986.39 ± 327.62   572.89 ± 125.74   3.78 ± 0.89   2.36 ± 0.44   24.97 ± 1.52   27.55 ± 5.59   13.52 ± 1.67   14.39 ± 3.30

F; female, M; male, NA; not available, 25-OHD; 25-hydroxy vitamin D, α-TE; α-tocopherol, α-TE/total lipids; α-tocopherol/sum of cholesterol and triglyceride, PTT; partial thromboplastin time, PT; prothrombin time, NA; not available. ^‡^McNemar test used for comparing data between before and after 28 days of a MCT-rich diet, categorized as deficient/ normal groups or abnormally prolonged/normal groups according to the cut-off values.

###### 

Plasma phospholipid fatty acids before and after treatment of chylothorax with an MCT-rich diet^†^

  Subject No.   LA^‡,^\*       ALA^‡^         OA^‡^         ARA^‡^        EPA^‡^         DHA^‡^                                                                               
  ------------- -------------- -------------- ------------- ------------- -------------- -------------- ------------- ------------- ------------- ------------- ------------- -------------
  1             NA             NA             NA            NA            NA             NA             NA            NA            NA            NA            NA            NA
  2             NA             NA             NA            NA            NA             NA             NA            NA            NA            NA            NA            NA
  3             24.5           16.00          0             0.60          28.35          36.39          5.82          3.05          0             0.24          0.59          1.25
  4             18.71          16.88          0             0             38.16          29.77          3.08          5.58          0             0             1.16          1.26
  5             28.48          9.98           0.48          0.19          29.68          36.30          3.57          4.27          0.14          0.22          1.86          0.81
  6             35.53          10.76          0.28          0.22          24.72          36.38          4.29          2.68          0             0.16          1.48          0.47
  7             14.74          13.77          0.24          0             30.01          30.28          4.94          3.84          0.20          0.19          1.85          1.40
  8             34.84          17.12          0.63          0.23          21.19          27.34          4.34          6.53          0.13          0.23          1.57          0.83
  9             19.94          15.22          0.08          0.13          32.49          27.40          4.06          3.03          0.16          0.15          0.80          0.53
                                                                                                                                                                              
  Mean ± SD     25.25 ± 8.06   14.25 ± 2.88   0.24 ± 0.24   0.17 ± 0.19   29.23 ± 5.43   32.12 ± 3.94   4.30 ± 0.89   4.15 ± 1.33   0.09 ± 0.08   0.15 ± 0.09   1.33 ± 0.49   0.82 ± 0.47

^†^Individual fatty acids presented as percentage of total fatty acids. ^‡^Paired Student *t* test used for comparing data between before and after a 28-day MCT-rich diet; \**p*\<0.05. LA; Linoleic acid, ALA; α-Linolenic acid, OA; Oleic acid, ARA; Arachidonic acid, EPA; Eicosapentaenoic acid, DHA; Docosahexaenoic acid, NA; not available.

###### 

Erythrocyte membrane fatty acids before and after treatment of chylothorax with an MCT-rich diet^†^

  Subject No.   LA^‡,^\*       ALA^‡^        OA^‡^         ARA^‡^        EPA^‡^         DHA^‡^                                                                                
  ------------- -------------- ------------- ------------- ------------- -------------- -------------- -------------- ------------- ------------- ------------- ------------- -------------
  1             NA             NA            NA            NA            NA             NA             NA             NA            NA            NA            NA            NA
  2             NA             NA            NA            NA            NA             NA             NA             NA            NA            NA            NA            NA
  3             12.59          8.77          0             0             19.96          27.65          11.51          9.37          0             0             1.24          3.66
  4             11.55          7.31          0             0             21.35          16.13          9.17           11.84         0             0             4.31          4.17
  5             13.98          6.01          0.19          0.34          16.01          18.59          10.61          11.76         0.30          0.36          5.25          4.42
  6             9.88           7.62          4.06          0.10          12.20          23.53          6.64           8.81          0.16          0.35          2.28          2.67
  7             8.36           1.77          0.09          0             16.27          5.90           12.62          0.48          0.32          0             5.33          0.21
  8             13.01          8.79          0.16          0             10.92          14.39          12.44          14.75         0.19          0.26          3.70          3.49
  9             9.00           7.99          0.08          0.09          16.37          15.72          12.94          11.70         0.41          0.38          2.66          3.15
                                                                                                                                                                              
  Mean ± SD     11.19 ± 2.15   6.89 ± 2.45   0.65 ± 1.50   0.08 ± 0.12   16.15 ± 3.75   17.41 ± 6.95   10.85 ± 2.27   9.81 ± 4.55   0.20 ± 0.16   0.19 ± 0.18   3.54 ± 1.55   3.11 ± 1.41

^†^Individual fatty acids presented as percentage of total fatty acids. ^‡^Paired Student *t* test used for comparing data between before and after treatment with the MCT-rich diet; \**p*\<0.05. LA; Linoleic acid, ALA; α-Linolenic acid, OA; Oleic acid, ARA; Arachidonic acid, EPA; Eicosapentaenoic acid, DHA; Docosahexaenoic acid, NA; not available.
